Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors
YH Dinakar, H Kumar, SL Mudavath, R Jain, R Ajmeer… - Life Sciences, 2022 - Elsevier
Introduction Breast cancer (BC) accounts for the majority of cancers among the female
population. Anomalous activation of various signaling pathways has become an issue of …
population. Anomalous activation of various signaling pathways has become an issue of …
[HTML][HTML] Gli1 promotes epithelial–mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating snail transcriptional activity and stability
X Lei, Z Li, Y Zhong, S Li, J Chen, Y Ke, S Lv… - … Pharmaceutica Sinica B, 2022 - Elsevier
Metastasis is crucial for the mortality of non-small cell lung carcinoma (NSCLC) patients. The
epithelial–mesenchymal transition (EMT) plays a critical role in regulating tumor metastasis …
epithelial–mesenchymal transition (EMT) plays a critical role in regulating tumor metastasis …
siRNA and targeted delivery systems in breast cancer therapy
Recently, nucleic acid drugs have been considered as promising candidates in treatment of
various diseases, especially cancer. Because of developing resistance to conventional …
various diseases, especially cancer. Because of developing resistance to conventional …
Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X
X Zhang, J Han, D Fan, J Wang, X Lin, H Zhang… - Cancer Gene …, 2023 - nature.com
Protein lysine succinylation (Ksucc) represents an important regulatory mechanism of tumor
development. In this work, the difference of protein Ksucc between HCMEC/D3 co-cultured …
development. In this work, the difference of protein Ksucc between HCMEC/D3 co-cultured …
The degradation of gelatin/alginate/fibrin hydrogels is cell type dependent and can be modulated by targeting fibrinolysis
E Boucard, L Vidal, F Coulon, C Mota… - … in bioengineering and …, 2022 - frontiersin.org
In tissue engineering, cell origin is important to ensure outcome quality. However, the impact
of the cell type chosen for seeding in a biocompatible matrix has been less investigated …
of the cell type chosen for seeding in a biocompatible matrix has been less investigated …
The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma
H Gao, J Yang, L He, W Wang, Y Liu, Y Hu, M Ge… - Frontiers in …, 2022 - frontiersin.org
Objective Methylation of the promoters of SHOX2 and RASSF1A are potentially informative
biomarkers for the diagnosis of early lung adenocarcinoma (LUAD). Abnormal methylation …
biomarkers for the diagnosis of early lung adenocarcinoma (LUAD). Abnormal methylation …
Positive feedback regulation of lncRNA TPT1‐AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer
C Cheng, D Liu, Z Liu, M Li, Y Wang, B Sun… - Cancer …, 2022 - Wiley Online Library
Emerging evidence has indicated that long noncoding RNAs (lncRNAs) are potential
biomarkers and play crucial roles in cancer development. However, the functions and …
biomarkers and play crucial roles in cancer development. However, the functions and …
SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway
W Yang, H Chen, L Ma, J Dong, M Wei, X Xue, Y Li… - IScience, 2023 - cell.com
The transcription factor SHOX2 gene is critical in regulating gene expression and the
development of tumors, but its biological role in prostate cancer (PCa) remains unclear. In …
development of tumors, but its biological role in prostate cancer (PCa) remains unclear. In …
Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation
J Liu, T Bian, B She, L Liu, H Sun, Q Zhang, J Zhu… - BMC cancer, 2024 - Springer
Methylation of the promoters of SHOX2 and RASSF1A (LungMe®) exhibits promise as a
potential molecular biomarker for diagnosing lung cancer. This study sought to assess the …
potential molecular biomarker for diagnosing lung cancer. This study sought to assess the …
A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
P Ren, JY Wang, ZR Zeng, NX Li, HL Chen… - Frontiers in …, 2022 - frontiersin.org
Hypoxia spontaneously forms in the interior of glioma tissues and regulates the expression
of various genes. However, the status of hypoxia-driven genes in glioma tissues is not …
of various genes. However, the status of hypoxia-driven genes in glioma tissues is not …